FDA DEVICE FACTS
MammoSightAI
Neurocareai, Inc. (Dba Savelife.Ai)
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
MammoSightAI is a software radiological workflow tool designed to assist radiologists in prioritizing exams within the standard-of-care image worklist for compatible FFDM and DBT screening mammograms. Utilizing an advanced artificial intelligence algorithm, MammoSightAI analyzes each mammogram and assigns a tag indicating the software's suspicion of at least one potentially suspicious finding. These assigned tags are seamlessly integrated into the hospital PACS or workstation, enabling worklist prioritization or triage to help radiologists focus on the most critical cases first. MammoSightAI is intended for passive notification only and does not provide any diagnostic information beyond triage and prioritization. Thus, it is not intended to replace the review of images or be used on a stand-alone basis for clinical decision-making. The interpreting radiologist is responsible for reviewing each exam on a diagnostic viewer and evaluating each patient according to the current standard of care.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。